Reuters logo
BRIEF-Cerus and Kedrion Biopharma enter distribution agreement for full INTERCEPT blood system portfolio
2017年10月31日 / 下午2点16分 / 19 天前

BRIEF-Cerus and Kedrion Biopharma enter distribution agreement for full INTERCEPT blood system portfolio

Oct 31 (Reuters) - Cerus Corp

* Cerus and Kedrion Biopharma enter distribution agreement for the full INTERCEPT blood system portfolio in Italy

* Says ‍entered into an agreement with Kedrion Biopharma to distribute full complement of INTERCEPT blood system products in italy​

* Says ‍Kedrion Biopharma will be sole distributor for intercept blood systems in Italy​

* Says ‍kedrion Biopharma will have right to distribute INTERCEPT red blood cells following CE mark approval​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below